This compound is a protected piperidine amino acid derivative designed for use as a pharmaceutical intermediate in peptide and small-molecule synthesis. Its structure incorporates a fluorenylmethoxycarbonyl (Fmoc) protecting group and a tert-butyl ether, enabling selective deprotection steps during drug manufacturing.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 3020708-18-0
(2S,4R)-4-(tert-butoxy)-1-{[(9H-fluoren-9-yl)methoxy]carbonyl}pyrrolidine-2-carboxylic acid
Fmoc-protected amino acid building block
N-Fmoc-(2S,5S)-5-tert-butoxypipecolicacid
Pharmaceutical intermediate
(2S,5R)-5-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)piperidine-2-carboxylic acid
pharmaceutical intermediate for peptide synthesis
3,4-Dichlorobenzoyl chloride
Pharmaceutical intermediate for lamotrigine
(3R,4S)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-1-phenylazetidin-2-one
Impurity standard for ezetimibe
2-N-Boc-Amino-thiazole-5-carboxylic acid
Boc-protected amino acid building block
N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide
Dasatinib intermediate
(2S,4S)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)piperidine-2-carboxylic acid
Pharmaceutical intermediate
(2S,4R)-1-(9H-fluoren-9-ylmethoxycarbonyl)-4-[(2-methylpropan-2-yl)oxy]piperidine-2-carboxylic acid
CVDIZXJOPDKIAY-ZHRRBRCNSA-N
CC(C)(C)O[C@@H]1CCN([C@@H](C1)C(=O)O)C(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24
—